baber/WOPTO huggingface dataset:
Patent MX-2020011096-A (MX)
Title: Electric vertical takeoff and landing aircraft.
Inventor: MELCHER THOMAS W
IPC: B64C29/00
Filed: 2019-04-24
Abstract: An aircraft has a boom, a propulsion assembly coupled to a first end of the boom, and a first wing coupled to a second end of the boom. The propulsion assembly is coupled to the boom by a rotating joint. A second wing is optionally coupled to the rotating joint. The first wing is coupled to the boom by a rotating joint. The first wing is coupled to the rotating joint by a hinge. A vehicle with roll, pitch, and yaw maneuverability able to mirror the aircraft movements may be coupled to the second end of the boom. The vehicle body may be picked up with a vehicle chassis disconnected from the vehicle body. The boom houses an energy source to power the propulsion assembly. A rudder is coupled to the second end of the boom. A paddle is disposed between the propulsion assembly and the boom.
Patent MX-2020011782-A (MX)
Title: Combination therapy involving antibodies against claudin 18.2 for treatment of cancer.
Inventor: MITNACHT-KRAUS RITA
IPC: A61K33/243
Filed: 2014-11-21
Abstract: The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.
Patent MX-2020012879-A (MX)
Title: Preservation compositions.
Inventor: STOTT IAN PETER
IPC: A61K8/368
Filed: 2019-05-20
Abstract: An antimicrobial preservation system comprising: i. itaconic acid or salt thereof and ii. benzoic acid or salt thereof.
Patent MX-2020013367-A (MX)
Title: Packaging material and method for providing a packaging material.
Inventor: LENNARTSSON MATTIAS
IPC: B65B9/20
Filed: 2019-07-05
Abstract: A packaging material having a core layer and inside and outside laminate portions is provided. The packaging material comprises a first area to form a first package, and a second area to form a second and adjacent package. The first area and the second area have a transversal sealing area between them, and the core layer is provided with at least one weakening portion at the transversal sealing area.
Patent MX-2020013509-A (MX)
Title: Compositions and methods for in vivo post translational modification.
Inventor: WEINER DAVID
IPC: C12N9/10
Filed: 2019-06-11
Abstract: The present invention provides methods of post-translationally modifying a synthetic protein in a subject. In one embodiment, the method comprises administering to the subject a composition comprising a first recombinant nucleic acid sequence encoding the synthetic protein, and a second recombinant nucleic acid sequence encoding a modifier protein, wherein the modifier protein post-translationally modifies the synthetic biologic in the subject. In one embodiment, the post translational modification is sulfation and the modifier protein is selected from the group consisting of tyrosylprotein sulfotransferase 1 (TPST1) and TPST2.
Patent MX-2020014190-A (MX)
Title: System and method for natural tasking of one or more robots.
Inventor: CHANG CHU-YIN
IPC: B25J9/16
Filed: 2019-07-02
Abstract: Embodiments of the present disclosure are directed towards a robotic system and method, which may include one or more robots. The system may include a robotic system having a maximum number of degrees of freedom. The system may further include a graphical user interface configured to receive a natural robot task having at least one natural workpiece constraint associated with the natural robot task. The system may also include a processor configured to identify a minimum number of degrees of freedom required to perform the natural robot task, wherein the minimum number of degrees of freedom is based upon, at least in part, the at least one natural workpiece constraint associated with the natural robot task.
Patent MX-2021000578-A (MX)
Title: Refrigeration appliance with detachable electronics module.
Inventor: KNATT KEVIN
IPC: F25C1/12
Filed: 2021-01-15
Abstract: A refrigeration appliance has an enclosure that defines an electronics module recess and a detachable electronics module that can be releasably retained in the recess. Tabs and tab receivers can be integrated with the electronics module and enclosure to releasably retain the electronics module in the recess. A trim piece can releasably attach to a display bezel of the electronics module by a snap-fit connection to retain the electronics module in the electronics module recess. In use, the electronics module can be selectively removed and a data acquisition device can be connected to the appliance using a data connector that is exposed by removing the electronics module.
Patent MX-2021001550-A (MX)
Title: Transglutaminase 2 (tg2) inhibitors.
Inventor: CAMPBELL DAVID
IPC: C07D403/06
Filed: 2019-08-09
Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit transglutaminase 2 (TG2). Also described herein are methods for using such TG2 inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from TG2 inhibition.
Patent MX-2021003326-A (MX)
Title: Control of clutchless vehicle electronic shift transmissions operating as bi-directional power transfer devices.
Inventor: BOWMAN JAY
IPC: B60K6/547
Filed: 2019-09-20
Abstract: Controlled clutchless shifting of multi-ratio geared electronic shift transmissions coupled directly to the electrical prime mover of a vehicle are disclosed. The adaptive control of electrically shifted manual transmissions incorporated into power-split series electric hybrid heavy vehicles operating over heavy duty drive cycles utilizes a direct coupling assembly that enables bi-directional energy transfer and power transport. An electronic shift transmission provides power amplifying or de-amplifying bi-directional intelligently controlled valve or pathway for available terrain potential or kinetic energy of a rolling mass of a vehicle, while retaining the original function of a transmission by increasing or decreasing mechanical rotating energy of the propulsion power to the rear wheels of a vehicle.
Patent MX-2021003987-A (MX)
Title: Treatment of pruritus with p2x3 antagonists.
Inventor: GARCEAU DENIS
IPC: A61K31/437
Filed: 2019-10-09
Abstract: Methods of treating pruritus in a mammal with a P2X3 antagonist are disclosed. Said P2X3 antagonist is preferably a compound of Formula (I). Said pruritus may be associated with an inflammatory skin disorder, an infectious skin disease, an autoimmune skin disease or a pregnancy-related skin disease. The P2X3 antagonist may be administered by intravenous administration, subcutaneous administration, oral administration, inhalation, nasal administration, topical administration or ophthalmic administration and may be used in conjunction with a NK-1 antagonist. The P2X3 antagonist acts by inhibiting pathological ATP release associated with hyperexcitability of afferent pruriceptive neurons, thus dampening peripheral hypersensitivity to itch via a broad mechanism independent on the pathological stimuli acting at itch receptors.
Patent MX-2021005732-A (MX)
Title: Method and device for simulating the visibility of a paint for a lidar sensor, which paint is applied to a surface.
Inventor: KANTIMM THOMAS
IPC: G01N21/55
Filed: 2019-11-15
Abstract: The invention relates to a method for simulating the visibility of a paint for a LIDAR sensor, which paint is applied to a surface, said method comprising at least the following steps: applying the paint to the surface (301); measuring the reflection of light having an operating wavelength of the LIDAR sensor by the surface painted with the paint at a plurality of illumination angles and/or measurement angles (302); adapting a bidirectional reflectance distribution function for the paint in dependence on the illumination angles and/or measurement angles to the respective measured reflections (303); simulating the propagation of the light emitted by the LIDAR sensor and reflected by the surface painted with the paint on the basis of the adapted bidirectional reflectance distribution function by means of a ray tracing application (304), the LIDAR sensor being simulated as a unit comprising a point light source and a camera, and the surface painted with the paint being simulated as a profile arranged at a variable distance and with a variable orientation in front of the camera; outputting a brightness image, which shows the brightness of the light reflected by the profile, in the direction of the LIDAR sensor, in accordance with the adapted bidirectional reflectance distribution function (305).
Patent MX-2021006590-A (MX)
Title: Isolated polynucleotides, polypeptides and methods of using same for increasing abiotic stress tolerance, biomass and yield of plants.
Inventor: VINOCUR BASIA JUDITH
IPC: C12N15/29
Filed: 2016-11-24
Abstract: Provided are isolated polypeptides which are at least 80% homologous to SEQ ID NOs: 552-897 and 6029-10629, isolated polynucleotides which are at least 80% identical to SEQ ID NOs: 1-551 and 898-6028, nucleic acid constructs comprising same, transgenic cells expressing same, transgenic plants expressing same and method of using same for increasing yield, abiotic stress tolerance, growth rate, biomass, vigor, oil content, photosynthetic capacity, seed yield, fiber yield, fiber quality, fiber length, and/or nitrogen use efficiency of a plant.
Patent MX-2021008639-A (MX)
Title: Bouillon tablet.
Inventor: TRAPPO GREGORY
IPC: A23L23/10
Filed: 2020-01-30
Abstract: The invention relates to a bouillon tablet comprising 20-70 wt% crystalline salt, up to 15 wt% crystalline sugar and 10-70 wt% pieces of plant material, wherein the crystalline salt has a median particle diameter Dv50 in the range of 0.7 to 3.5 mm, wherein the crystalline sugar has a median particle diameter Dv50 in the range of 0.5 to 3.5 mm and the pieces of plant material have a median particle diameter Dv50 in the range of 0.7 to 9.0 mm.
Patent MX-2021009612-A (MX)
Title: Systems for treating a metal substrate.
Inventor: NAKAJIMA MASAYUKI
IPC: C23C22/83
Filed: 2020-02-11
Abstract: Disclosed herein are systems for treating a substrate. The system may include a cleaner composition, a deoxidizing composition comprising a Group IVA metal and/or a Group IVB metal and free fluoride and having a pH of 1.0 to 3.0, and/or a seal composition. The system may also include a coating composition. The cleaner composition, deoxidizing composition, and/or seal composition may comprise a homopolymer or a copolymer comprising a phosphorous-containing monomeric subunit m1. Also disclosed is a deoxidizing composition comprising a Group IVA metal and a Group IVB metal and free fluoride and having a pH of 1.0 to 3.0. Also disclosed are methods of treating a substrate. Also disclosed are treated substrates.
Patent MX-2021010354-A (MX)
Title: Glycoengineered antibody drug conjugates.
Inventor: ZHOU QUN
IPC: C07K16/28
Filed: 2017-04-07
Abstract: The current disclosure provides binding polypeptides (e.g., antibodies), and targeting moiety conjugates thereof, comprising a site- specifically engineered glycan linkage within native or engineered glycans of the binding polypeptide. The current disclosure also provides nucleic acids encoding the antigen-binding polypeptides, recombinant expression vectors and host cells for making such antigen-binding polypeptides. Methods of using the antigen-binding polypeptides disclosed herein to treat disease are also provided.
Patent MX-2021015523-A (MX)
Title: Free-cutting copper alloy casting, and method for producing free-cutting copper alloy casting.
Inventor: OISHI KEIICHIRO
IPC: C22C9/04
Filed: 2020-02-17
Abstract: This copper allow casting comprises, 58.5-65.0 mass% (exclusive of 58.5 and 65.0) of Cu, 0.40-1.40 mass% (exclusive of 0.40 and 1.40) of Si, 0.002-0.25 mass% (exclusive of 0.002 and 0.25) of Pb, 0.003-0.19 mass% of P (exclusive of 0.003 and 0.19), 0.0001-0.100 mass% of Bi as an optional element, and the balance being Zn and inevitable impurities, wherein: the total amount of Fe, Mn, Co and Cr is less than 0.45 mass%; the total amount of Sn and Al is less than 0.45%; the relationship 56.0â¤f1=[Cu]-5Ã[Si]+0.5Ã[Pb]+0.5Ã[Bi]-0.5Ã[P]â¤59.5 is satisfied; the relationship 0.003<f0=[Pb]+[Bi]<0.25 is further satisfied when Bi is included; and the constituent phase of a metal structure has the relationship 20â¤(Î±)â¤80, 18â¤(Î²)â¤80, 0â¤(Î³)<5, 20Ã(Î³)/(Î²)<4, 18â¤(Î³)1/2Ã3+(Î²)Ã(-0.5Ã[Si]2+1.5Ã[ Si])â¤82, 33â¤(Î³)1/2Ã3+(Î²)Ã(-0.5Ã[Si]2+1.5Ã[ Si])+([Pb]+[Bi])1/2Ã38+([P])1/2Ã15, a P-containing compound being present in the Î² phase.
Patent MX-2022001274-A (MX)
Title: Serotonergic agent and 5-ht1a-receptor antagonist.
Inventor: WALDINGER - (FINADO) Marcel David
IPC: A61K31/4525
Filed: 2020-07-29
Abstract: The present invention relates to a 5-HT1A-receptor antagonist or a derivative, precursor or metabolite thereof, in combination with at least one serotonergic agent or a derivative, precursor or metabolite thereof for use in the prevention and/or treatment of premature ejaculation, wherein the 5-HT1A-receptor antagonist or a derivative, precursor or metabolite thereof is administered separately, sequentially or simultaneously to the at least one serotonergic agent or a derivative, precursor or metabolite thereof.
Patent MX-2022002060-A (MX)
Title: A prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells.
Inventor: RAO VENIGALLA B
IPC: C12N15/86
Filed: 2020-08-12
Abstract: Described is hybrid viral vector comprising: a first virus such as bacteriophage T4; one or more second virus such as adeno-associated virus (AAV) attached to the first virus through cross-bridges, such as avidin-biotin cross-bridges; one or more DNA molecules packaged in the first virus; one or more nucleic acid molecules packaged in the second virus; and one or more proteins displayed on the surface of the first virus. Also described are methods of making and using such a hybrid viral vector.
Patent MX-2022002636-A (MX)
Title: Treatment of liver disease or disorder comprising actrii receptor antagonists.
Inventor: ROUBENOFF RONENN
IPC: C07K16/28
Filed: 2020-09-01
Abstract: The present disclosure provides an ActRII antagonist, e.g., the ActRIIA and/or ActRIIB antagonist, e.g., an anti-ActRII receptor antibody or antigen-binding fragment thereof, e.g., bimagrumab, for treating or preventing liver disease or disorder in a subject in need thereof. The present disclosure also relates to pharmaceutical combinations comprising such ActRII antagonists and at least one further therapeutic agent in the treatment or prevention of liver disease or disorder.
Patent MX-2022004021-A (MX)
Title: Breast implant system.
Inventor: FORSELL PETER
IPC: A61F2/12
Filed: 2010-07-29
Abstract: A breast implant system is provided comprising a plurality of chambers including one or more first fluid chambers (1 ) and one or more second fluid chambers (2). The first fluid chamber (1 ) forms part of a breast implant (10), whereas the second fluid chamber (2) may also form part of the breast implant or may be implanted remote from the breast implant. The first and second fluid chambers are interconnected so as to allow exchange of fluid between the first and second chambers, thereby causing the shape and, depending upon the specific embodiment, also the volume to change accordingly.
Patent MX-2022004840-A (MX)
Title: Light stable natural yellow colorant systems in pickled and fermented vegetable applications.
Inventor: Dabas Deepti
IPC: A23B7/10
Filed: 2020-10-21
Abstract: The present invention comprises a novel natural yellow colorant system to enhance the appearance of pickled and/or fermented vegetable products. Individually all-natural yellow pigments failed light stability investigations in pickled and/or fermented vegetable products - either the yellow hue of the brine solution faded, or the pulp/skin of the vegetable turned white, or both. Surprisingly combinations of these same individual natural yellow pigments not only created brine hues and vegetable coloring comparable to FD&C Yellow # 5 products but remained stable in accelerated light stability investigations designed to mimic the real-time shelf-life of the products.
Patent MX-2022006841-A (MX)
Title: Modulators of the immune escape mechanism for universal cell therapy.
Inventor: ALICI EVREN
IPC: C07K16/28
Filed: 2020-12-07
Abstract: Therapeutic agents capable of detaining bulky proteins such as CD45, CD148, and CD43 in the middle of the cellular interface between a graft cell and CD45 positive host effector cell (such as a T cell, NK cell, B cell, or dendritic cell) are disclosed, as are methods for their use and products made with such therapeutic agents. The therapeutic agents prevent or inhibit the formation of functional immunologic synapses (including physiological SMAC). They also result in continuous dephosphorylation of signal transduction pathways.
Patent MX-2022007304-A (MX)
Title: Use of lemborexant for treating insomnia.
Inventor: MOLINE MARGARET
IPC: A61K31/506
Filed: 2020-12-18
Abstract: Disclosed are methods for treating insomnia, comprising administering orally a dosage form comprising lemborexant or a pharmaceutically acceptable salt thereof to a patient in need thereof at a single daily dose ranging from 5 mg to 10 mg of lemborexant or an equivalent dose of a pharmaceutically acceptable salt thereof, provided that the maximum dose is 5 mg once per day of lemborexant or an equivalent dose of a pharmaceutically acceptable salt thereof when the patient has moderate hepatic impairment classified in Child-Pugh class B under Child-Pugh Classification.
Patent MX-2022009126-A (MX)
Title: Method for evaluating quality of (3s)-3-(4-(3-(1,4-dioxaspiro[4,5 ]dec-7-en-8-yl)benzyloxy)phenyl)hex-4-inoic acid.
Inventor: CHOI SU KYOUNG
IPC: G01N30/04
Filed: 2021-01-29
Abstract: The present invention provides a related substance of (3S)-3-(4-(3-(1,4-dioxaspiro[4,5]dec-7-en-8-yl)benzyloxy)phenyl )hex-4-inoic acid, and a method for evaluating the quality of (3S)-3-(4-(3-(1,4-dioxaspiro[4,5]dec-7-en-8-yl)benzyloxy)phenyl )hex-4-inoic acid by using same. According to the present invention, It is possible to evaluate the quality and the stability of a pharmaceutical composition comprising (3S)-3-(4-(3-(1,4-dioxaspiro[4,5]dec-7-en-8-yl)benzyloxy)phenyl )hex-4-inoic acid by using a compound of formula 2 or a salt thereof as a reference standard.
Patent MX-2022009707-A (MX)
Title: Sars-cov-2 mrna domain vaccines.
Inventor: STEWART-JONES GUILLAUME
IPC: A61K39/215
Filed: 2021-02-06
Abstract: The disclosure relates to coronavirus ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines. The RNA vaccines encode domains and subunits of coronavirus.
Patent MX-2022009891-A (MX)
Title: Structure for therapeutic applications.
Inventor: GERSTENMEIER JÜRGEN
IPC: A61H9/00
Filed: 2021-02-17
Abstract: Disclosed is a structure (10) for therapeutic applications comprising at least one layer (2) with sensor elements (5, 6, 7) and heating elements (8). A first force (11) affects the layer (2) from one side and a second force (12) affects the layer (2) from the other side. The forces are detectable. The sensor elements (5, 6, 7) can comprise, for example, position sensors 6, pressure sensors 7, and temperature sensors.
Patent MX-2022012359-A (MX)
Title: Formulation.
Inventor: ANDRES PHILIPPE
IPC: A61K9/00
Filed: 2021-03-26
Abstract: The invention relates to formulations comprising a halogenated salicylanilide, or a pharmaceutically acceptable salt thereof, and a cyclodextrin. The formulations may be in the form of a liquid formulation, particularly an aqueous formulation, and provide high concentrations of solubilised halogenated salicylanilide. Also disclosed a formulations in the form of powders and aerosols. Also disclosed are the formulations for use in the treatment of bacterial and viral infections, and the treatment of inflammatory diseases. The formulations are particularly suitable for administration by inhalation for the treatment of bacterial and viral pulmonary infections and the treatment of pulmonary inflammatory diseases.
Patent MX-2022012727-A (MX)
Title: Cucumber plant habit.
Inventor: SHERMAN TAL
IPC: C12N15/82
Filed: 2021-04-12
Abstract: The present invention disclosure relates to conferring desirable agronomic traits in Cucumber plants. More particularly, the present invention discloses a modified Cucumber plant exhibiting at least one improved domestication trait. The modified Cucumber plant comprises at least one genetic modification conferring reduced expression of at least one Cucumber SELF PRUNING (SP) (CuSP) gene. The present disclosure further provides methods for producing the aforementioned modified Cucumber plant and uses thereof.
Patent MX-2022014143-A (MX)
Title: Use of carboxymethylated polymer of lysines as dispersing agent and compositions comprising the same.
Inventor: ESPER CLAUDIA
IPC: C11D3/39
Filed: 2021-05-05
Abstract: The present invention is in relation to use of carboxymethylated polylysines as a dispersing agent and/or chelating agent. The present invention is also in relation to detergent compositions and peroxy bleaching compositions comprising carboxymethylated polylysines. The present invention further relates to a method for formulating a detergent composition or a peroxy bleaching composition with the carboxymethylated polylysines.
Patent MX-PA00001613-A (MX)
Title: Enzymatic cleaning compositions
Inventor: BETTIOL JEAN-LUC
IPC: C12N9/00
Filed: 2000-02-15
Abstract: The present invention relates to laundry detergent compositions, comprising a saccharide gum degrading enzyme providing excellent cleaning performance, especially food stain/soil removal, dingy cleaning and whiteness benefits.
Patent MX-PA01002463-A (MX)
Title: Antimicrobial treatment of polymers.
Inventor: KIM YOUNG HEE
IPC: A01N25/34
Filed: 1999-09-10
Abstract: The present invention provides durable and refreshable antimicrobial polymers and methods for preparing the same. In some instances, the polymer is a textile. These textiles have excellent colorfastness and washfastness. The antimicrobial fabrics of this invention are suitable for sportswear, antiodor carpets, films, plastics, toys and medical uses.
Patent MX-PA01010273-A (MX)
Title: Novel recombinant and mutant herpesviruses.
Inventor: JUNKER DAVID E
IPC: A61K35/76
Filed: 2000-04-07
Abstract: The present invention provides methods and reagents for inducing active immunity in animals. In particular, the present invention provides recombinant herpesviruses having foreign DNA that are capable of inducing immunity to the herpesvirus and/or the source of the foreigh DNA. The present invention also provides mutant herpesviruses having portions of their genome deleted. Preferably, foreign DNA is introduced, or portions of the genome are deleted, in the UL54.5 open reading frame of avian herperviruses or the UL43 open reading frame of Marek's disease virus.